Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years
Thirty-two cases of sarcomas involving the oral and maxillofacial region over a period of 25 years were reviewed. The age range was from 5 months to 77 years with a mean age of 42. The male to female ratio was 3:1. The sarcomas were located in the maxilla including the maxillary sinus (n= 13), mandi...
Gespeichert in:
| Veröffentlicht in: | Clinical oral investigations 2004-06, Vol.8 (2), p.52-55 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 55 |
|---|---|
| container_issue | 2 |
| container_start_page | 52 |
| container_title | Clinical oral investigations |
| container_volume | 8 |
| creator | Yamaguchi, Satoshi Nagasawa, Hirokazu Suzuki, Tetsuo Fujii, Eiji Iwaki, Hiroshi Takagi, Minoru Amagasa, Teruo |
| description | Thirty-two cases of sarcomas involving the oral and maxillofacial region over a period of 25 years were reviewed. The age range was from 5 months to 77 years with a mean age of 42. The male to female ratio was 3:1. The sarcomas were located in the maxilla including the maxillary sinus (n= 13), mandible (n= 13), buccal mucosa (n= 3), temporomandibular fossa (n= 2), and submandibular region (n= 1). Histologically sarcomas were classified as osteosarcoma (n= 9), malignant fibrous histiocytoma (n= 7), rhabdomyosarcoma (n= 5), fibrosarcoma (n= 3), plasmacytoma (n= 2), leiomyosarcoma (n= 2), angiosarcoma (n= 2), liposarcoma (n= 1), and ameloblastic fibrosarcoma (n= 1). Surgical resection was performed in 29 cases. Local recurrence was found in 10 patients and metastasis in 11 patients. Metastases included five regional lymph node metastases and eight distant metastases. The survival of patients with local recurrence or metastasis was poor. Surgery is the most reliable treatment for sarcomas of the oral and maxillofacial region. Adequate excision with safety surgical margin as the initial therapy is important for better survival. The value of radiation therapy and/or chemotherapy is uncertain. The 5-year survival rate of primary cases was 61%. |
| doi_str_mv | 10.1007/s00784-003-0233-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66746306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>972407141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-df72c51a44ce88e0a63ea96f1da65da06a07189c565aa781d9e218b73b8b4c523</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMoVqs_wIsED95WM_lebyJ-gdCDeg7TbFa37G5q0qr9925tQfAyMwzPOwwPISfALoAxc5mHYmXBmCgYF6KQO-QApNCFMAZ2f2de6NLCiBzmPGMMpDZin4xAcQsczAGZPGPyscNMY00X74HGhC3FvqIdfjdtG2v0zbBJ4a2J_RXFYfpswtcaF5x6zCHTpqdc0VXAlI_IXo1tDsfbPiavd7cvNw_F0-T-8eb6qfCCqUVR1YZ7BSilD9YGhloELHUNFWpVIdPIDNjSK60QjYWqDBzs1IipnUqvuBiT883deYofy5AXrmuyD22LfYjL7LQ2UgumB_DsHziLy9QPvznOSw1KcTlAsIF8ijmnULt5ajpMKwfMrVW7jWo3qHZr1W6dOd0eXk67UP0ltm7FD5tkdvw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229615524</pqid></control><display><type>article</type><title>Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Yamaguchi, Satoshi ; Nagasawa, Hirokazu ; Suzuki, Tetsuo ; Fujii, Eiji ; Iwaki, Hiroshi ; Takagi, Minoru ; Amagasa, Teruo</creator><creatorcontrib>Yamaguchi, Satoshi ; Nagasawa, Hirokazu ; Suzuki, Tetsuo ; Fujii, Eiji ; Iwaki, Hiroshi ; Takagi, Minoru ; Amagasa, Teruo</creatorcontrib><description>Thirty-two cases of sarcomas involving the oral and maxillofacial region over a period of 25 years were reviewed. The age range was from 5 months to 77 years with a mean age of 42. The male to female ratio was 3:1. The sarcomas were located in the maxilla including the maxillary sinus (n= 13), mandible (n= 13), buccal mucosa (n= 3), temporomandibular fossa (n= 2), and submandibular region (n= 1). Histologically sarcomas were classified as osteosarcoma (n= 9), malignant fibrous histiocytoma (n= 7), rhabdomyosarcoma (n= 5), fibrosarcoma (n= 3), plasmacytoma (n= 2), leiomyosarcoma (n= 2), angiosarcoma (n= 2), liposarcoma (n= 1), and ameloblastic fibrosarcoma (n= 1). Surgical resection was performed in 29 cases. Local recurrence was found in 10 patients and metastasis in 11 patients. Metastases included five regional lymph node metastases and eight distant metastases. The survival of patients with local recurrence or metastasis was poor. Surgery is the most reliable treatment for sarcomas of the oral and maxillofacial region. Adequate excision with safety surgical margin as the initial therapy is important for better survival. The value of radiation therapy and/or chemotherapy is uncertain. The 5-year survival rate of primary cases was 61%.</description><identifier>ISSN: 1432-6981</identifier><identifier>EISSN: 1436-3771</identifier><identifier>DOI: 10.1007/s00784-003-0233-4</identifier><identifier>PMID: 15281217</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Adult ; Age Factors ; Aged ; Child ; Dentistry ; Female ; Follow-Up Studies ; Histiocytoma, Benign Fibrous - epidemiology ; Humans ; Infant ; Japan - epidemiology ; Jaw Neoplasms - epidemiology ; Lymphatic Metastasis ; Male ; Middle Aged ; Mouth Neoplasms - epidemiology ; Neoplasm Recurrence, Local - epidemiology ; Osteosarcoma - epidemiology ; Retrospective Studies ; Rhabdomyosarcoma - epidemiology ; Sarcoma - epidemiology ; Sex Factors ; Survival Rate ; Treatment Outcome</subject><ispartof>Clinical oral investigations, 2004-06, Vol.8 (2), p.52-55</ispartof><rights>Springer-Verlag 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c305t-df72c51a44ce88e0a63ea96f1da65da06a07189c565aa781d9e218b73b8b4c523</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15281217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaguchi, Satoshi</creatorcontrib><creatorcontrib>Nagasawa, Hirokazu</creatorcontrib><creatorcontrib>Suzuki, Tetsuo</creatorcontrib><creatorcontrib>Fujii, Eiji</creatorcontrib><creatorcontrib>Iwaki, Hiroshi</creatorcontrib><creatorcontrib>Takagi, Minoru</creatorcontrib><creatorcontrib>Amagasa, Teruo</creatorcontrib><title>Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years</title><title>Clinical oral investigations</title><addtitle>Clin Oral Investig</addtitle><description>Thirty-two cases of sarcomas involving the oral and maxillofacial region over a period of 25 years were reviewed. The age range was from 5 months to 77 years with a mean age of 42. The male to female ratio was 3:1. The sarcomas were located in the maxilla including the maxillary sinus (n= 13), mandible (n= 13), buccal mucosa (n= 3), temporomandibular fossa (n= 2), and submandibular region (n= 1). Histologically sarcomas were classified as osteosarcoma (n= 9), malignant fibrous histiocytoma (n= 7), rhabdomyosarcoma (n= 5), fibrosarcoma (n= 3), plasmacytoma (n= 2), leiomyosarcoma (n= 2), angiosarcoma (n= 2), liposarcoma (n= 1), and ameloblastic fibrosarcoma (n= 1). Surgical resection was performed in 29 cases. Local recurrence was found in 10 patients and metastasis in 11 patients. Metastases included five regional lymph node metastases and eight distant metastases. The survival of patients with local recurrence or metastasis was poor. Surgery is the most reliable treatment for sarcomas of the oral and maxillofacial region. Adequate excision with safety surgical margin as the initial therapy is important for better survival. The value of radiation therapy and/or chemotherapy is uncertain. The 5-year survival rate of primary cases was 61%.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Child</subject><subject>Dentistry</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Histiocytoma, Benign Fibrous - epidemiology</subject><subject>Humans</subject><subject>Infant</subject><subject>Japan - epidemiology</subject><subject>Jaw Neoplasms - epidemiology</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Neoplasms - epidemiology</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Osteosarcoma - epidemiology</subject><subject>Retrospective Studies</subject><subject>Rhabdomyosarcoma - epidemiology</subject><subject>Sarcoma - epidemiology</subject><subject>Sex Factors</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>1432-6981</issn><issn>1436-3771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkE1LAzEQhoMoVqs_wIsED95WM_lebyJ-gdCDeg7TbFa37G5q0qr9925tQfAyMwzPOwwPISfALoAxc5mHYmXBmCgYF6KQO-QApNCFMAZ2f2de6NLCiBzmPGMMpDZin4xAcQsczAGZPGPyscNMY00X74HGhC3FvqIdfjdtG2v0zbBJ4a2J_RXFYfpswtcaF5x6zCHTpqdc0VXAlI_IXo1tDsfbPiavd7cvNw_F0-T-8eb6qfCCqUVR1YZ7BSilD9YGhloELHUNFWpVIdPIDNjSK60QjYWqDBzs1IipnUqvuBiT883deYofy5AXrmuyD22LfYjL7LQ2UgumB_DsHziLy9QPvznOSw1KcTlAsIF8ijmnULt5ajpMKwfMrVW7jWo3qHZr1W6dOd0eXk67UP0ltm7FD5tkdvw</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Yamaguchi, Satoshi</creator><creator>Nagasawa, Hirokazu</creator><creator>Suzuki, Tetsuo</creator><creator>Fujii, Eiji</creator><creator>Iwaki, Hiroshi</creator><creator>Takagi, Minoru</creator><creator>Amagasa, Teruo</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200406</creationdate><title>Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years</title><author>Yamaguchi, Satoshi ; Nagasawa, Hirokazu ; Suzuki, Tetsuo ; Fujii, Eiji ; Iwaki, Hiroshi ; Takagi, Minoru ; Amagasa, Teruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-df72c51a44ce88e0a63ea96f1da65da06a07189c565aa781d9e218b73b8b4c523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Child</topic><topic>Dentistry</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Histiocytoma, Benign Fibrous - epidemiology</topic><topic>Humans</topic><topic>Infant</topic><topic>Japan - epidemiology</topic><topic>Jaw Neoplasms - epidemiology</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Neoplasms - epidemiology</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Osteosarcoma - epidemiology</topic><topic>Retrospective Studies</topic><topic>Rhabdomyosarcoma - epidemiology</topic><topic>Sarcoma - epidemiology</topic><topic>Sex Factors</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Satoshi</creatorcontrib><creatorcontrib>Nagasawa, Hirokazu</creatorcontrib><creatorcontrib>Suzuki, Tetsuo</creatorcontrib><creatorcontrib>Fujii, Eiji</creatorcontrib><creatorcontrib>Iwaki, Hiroshi</creatorcontrib><creatorcontrib>Takagi, Minoru</creatorcontrib><creatorcontrib>Amagasa, Teruo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical oral investigations</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Satoshi</au><au>Nagasawa, Hirokazu</au><au>Suzuki, Tetsuo</au><au>Fujii, Eiji</au><au>Iwaki, Hiroshi</au><au>Takagi, Minoru</au><au>Amagasa, Teruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years</atitle><jtitle>Clinical oral investigations</jtitle><addtitle>Clin Oral Investig</addtitle><date>2004-06</date><risdate>2004</risdate><volume>8</volume><issue>2</issue><spage>52</spage><epage>55</epage><pages>52-55</pages><issn>1432-6981</issn><eissn>1436-3771</eissn><abstract>Thirty-two cases of sarcomas involving the oral and maxillofacial region over a period of 25 years were reviewed. The age range was from 5 months to 77 years with a mean age of 42. The male to female ratio was 3:1. The sarcomas were located in the maxilla including the maxillary sinus (n= 13), mandible (n= 13), buccal mucosa (n= 3), temporomandibular fossa (n= 2), and submandibular region (n= 1). Histologically sarcomas were classified as osteosarcoma (n= 9), malignant fibrous histiocytoma (n= 7), rhabdomyosarcoma (n= 5), fibrosarcoma (n= 3), plasmacytoma (n= 2), leiomyosarcoma (n= 2), angiosarcoma (n= 2), liposarcoma (n= 1), and ameloblastic fibrosarcoma (n= 1). Surgical resection was performed in 29 cases. Local recurrence was found in 10 patients and metastasis in 11 patients. Metastases included five regional lymph node metastases and eight distant metastases. The survival of patients with local recurrence or metastasis was poor. Surgery is the most reliable treatment for sarcomas of the oral and maxillofacial region. Adequate excision with safety surgical margin as the initial therapy is important for better survival. The value of radiation therapy and/or chemotherapy is uncertain. The 5-year survival rate of primary cases was 61%.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>15281217</pmid><doi>10.1007/s00784-003-0233-4</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1432-6981 |
| ispartof | Clinical oral investigations, 2004-06, Vol.8 (2), p.52-55 |
| issn | 1432-6981 1436-3771 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66746306 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Age Factors Aged Child Dentistry Female Follow-Up Studies Histiocytoma, Benign Fibrous - epidemiology Humans Infant Japan - epidemiology Jaw Neoplasms - epidemiology Lymphatic Metastasis Male Middle Aged Mouth Neoplasms - epidemiology Neoplasm Recurrence, Local - epidemiology Osteosarcoma - epidemiology Retrospective Studies Rhabdomyosarcoma - epidemiology Sarcoma - epidemiology Sex Factors Survival Rate Treatment Outcome |
| title | Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T11%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sarcomas%20of%20the%20oral%20and%20maxillofacial%20region:%20a%20review%20of%2032%20cases%20in%2025%20years&rft.jtitle=Clinical%20oral%20investigations&rft.au=Yamaguchi,%20Satoshi&rft.date=2004-06&rft.volume=8&rft.issue=2&rft.spage=52&rft.epage=55&rft.pages=52-55&rft.issn=1432-6981&rft.eissn=1436-3771&rft_id=info:doi/10.1007/s00784-003-0233-4&rft_dat=%3Cproquest_cross%3E972407141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229615524&rft_id=info:pmid/15281217&rfr_iscdi=true |